Ways to help
About us
Contact Us
Feb 2017
Trish Foundation contributes to first-ever discovery
Jun 2017
Researchers funded by the Trish Foundation making great progress
Dec 2014
2015 Funding announced
Mar 2015
Investigating new treatment options
Oct 2015
Progress in MS Research Conference
Feb 2016
2016 Round of Funding
Sep 2016
Dr Gu's Incubator Grant announced
Jan 2017
New Research Projects commencing 2017 announced

Inaugural Betty Cuthbert

Postdoctoral Fellowship - 2006-2009 


Dr Helmut Butzkueven’s research for four years, funded by the Trish Multiple Sclerosis Research Foundation and NHMRC Betty Cuthbert Postdoctoral Fellowship, was aimed at identifying some of the natural repair processes and assess whether treatments designed to enhance naturally occurring repair may provide additional treatment benefit.  The key interest in this respect is MS-related axonal injury. Axons, the cables transmitting electricity between cells of the nervous system do not regenerate when cut (trans-sected) by autoimmune damage, but not all axons in areas of damage die.  

Dr Butzkueven fulfilled the two main aims of this Fellowship. Firstly, together with his collaborators, he was able to directly measure axon damage in mice using a special MRI scanning technique known as diffusion scanning. The next step he undertook confirmed these findings in people with MS and therefore paved the way for development of new MS treatments.  

Secondly, he confirmed that the neuroprotective drug LIF, which enhances naturally occurring brain defences, directly protects both myelin and axons from immune damage in the MS mouse model. As a result of this and prior work, LIF will be developed as a treatment for MS.

Trish Foundation & MS Research Australia Working together to find a cure for MS
Copyright © Trish Multiple Sclerosis Research Foundation. All rights reserved.